The L-type calcium channel is the major calcium influx pathway in vascular smooth muscle and is regulated by integrin ligands, suggesting an important link between extracellular matrix and vascular tone regulation in tissue injury and remodeling. We examined the role of integrin-linked tyrosine kinases and focal adhesion proteins in regulation of L-type calcium current in single vascular myocytes. Soluble tyrosine kinase inhibitors blocked the increase in current produced by ␣ 5 integrin antibody or fibronectin, whereas tyrosine phosphatase inhibition enhanced the effect. Cell dialysis with an antibody to focal adhesion kinase or with FRNK, the C-terminal noncatalytic domain of focal adhesion kinase, produced moderate (24 or 18%, respectively) inhibition of basal current but much greater inhibition (63 or 68%, respectively) of integrin-enhanced current. A c-Src antibody and peptide inhibitors of the Src homology-2 domain or a putative Src tyrosine phosphorylation site on the channel produced similar inhibition. Antibodies to the cytoskeletal proteins paxillin and vinculin, but not ␣-actinin, inhibited integrin-dependent current by 65-80%. Therefore, ␣ 5 ␤ 1 integrin appears to regulate a tyrosine phosphorylation cascade involving Src and various focal adhesion proteins that control the function of the L-type calcium channel. This interaction may represent a novel mechanism for control of calcium influx in vascular smooth muscle and other cell types.
The L-type calcium channel is the major calcium influx pathway in vascular smooth muscle and is regulated by integrin ligands, suggesting an important link between extracellular matrix and vascular tone regulation in tissue injury and remodeling. We examined the role of integrin-linked tyrosine kinases and focal adhesion proteins in regulation of L-type calcium current in single vascular myocytes. Soluble tyrosine kinase inhibitors blocked the increase in current produced by ␣ 5 integrin antibody or fibronectin, whereas tyrosine phosphatase inhibition enhanced the effect. Cell dialysis with an antibody to focal adhesion kinase or with FRNK, the C-terminal noncatalytic domain of focal adhesion kinase, produced moderate (24 or 18%, respectively) inhibition of basal current but much greater inhibition (63 or 68%, respectively) of integrin-enhanced current. A c-Src antibody and peptide inhibitors of the Src homology-2 domain or a putative Src tyrosine phosphorylation site on the channel produced similar inhibition. Antibodies to the cytoskeletal proteins paxillin and vinculin, but not ␣-actinin, inhibited integrin-dependent current by 65-80%. Therefore, ␣ 5 ␤ 1 integrin appears to regulate a tyrosine phosphorylation cascade involving Src and various focal adhesion proteins that control the function of the L-type calcium channel. This interaction may represent a novel mechanism for control of calcium influx in vascular smooth muscle and other cell types.
Mechanical forces are known to stimulate a number of cell signaling pathways, including those initiated by or resulting in ion channel activation. Several types of ion channels exhibit mechanosensitivity, but the mechanisms underlying their gating remain unclear. Membrane tension changes induced by physiologically relevant forces may not be sufficiently large to gate channels directly in eukaryotic cells (1) . Thus, it is likely that mechanically advantageous associations with cytoskeletal or other membrane-bound proteins play a key role in control of gating. However, some mechanism must exist to integrate mechanosensitive gating behavior with the primary regulatory mechanism for channel gating, which is phosphorylation of channel proteins by intracellular kinases (2) .
Integrins are potential force transduction proteins because they span the plasma membrane and link the extracellular matrix (ECM) 1 to the underlying actin cytoskeleton (CSK) in specialized focal contact regions. Stress applied through integrin-specific adhesion sites increases cytoskeletal stiffening (3), activates second messenger formation (4) and initiates ribosomal and mRNA recruitment to focal adhesions (5) . Integrin clustering by multivalent ligands, including ECM proteins, induces recruitment of CSK proteins including vinculin, talin, paxillin and tensin to the focal contact (6, 7) . Kinases such as focal adhesion kinase (FAK), Src, PLC-␥, and Rho GTPase, as well as adaptor proteins such as Grb2, Sos, and Shc, are also recruited to the ECM-integrin binding site (8, 9) . Subsequently, phosphorylation cascades are initiated involving one or more tyrosine kinases.
We recently described functional coupling between integrins and the L-type calcium channel in vascular smooth muscle (VSM) (10) . This channel is the primary calcium entry pathway in VSM and can exhibit mechanosensitive gating under certain conditions (11, 12) . It is regulated by at least two integrins. Soluble or bound ligands of the ␣ v ␤ 3 (vitronectin) receptor inhibit whole-cell, L-type current through RGDdependent interactions. In contrast, only insoluble ligands of the ␣ 5 ␤ 1 (fibronectin) integrin enhance L-type current. Soluble ␣ 5 ␤ 1 ligands such as monoclonal antibodies activate current only if they are clustered using a secondary antibody (10) , suggesting that an integrin-linked signaling pathway may be involved (13) .
The purpose of the present study was to determine the mechanism by which the L-type channel in VSM is regulated by ␣ 5 ␤ 1 -ECM interactions. Our results indicate that a tyrosine phosphorylation cascade is required for the regulation of the L-type calcium channel by ␣ 5 ␤ 1 ligands. Furthermore, the pathway appears to be constitutively active, with FAK and c-Src as components. The involvement of these kinases suggests there may be overlap or convergence of the signaling pathway with those described for growth factor receptors (14, 15) . This integrin-linked pathway represents a potential mechanism whereby calcium entry, and therefore vascular tone, can be regulated by mechanical forces and integrin-matrix interactions.
EXPERIMENTAL PROCEDURES
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§ To whom correspondence should be addressed: Dept. 4 , 10 HEPES, 4.17 NaHCO 3 ; 1 mg/ml bovine serum albumin; pH was adjusted to 7.4 with NaOH) at room temperature for 10 min after which 26 units/ml papain (Sigma) and 1 mg/ml dithioerythritol (Sigma) were added, and the vessels were incubated for 30 min at 37°C with occasional agitation. Vessel fragments were transferred to low Ca 2ϩ saline solution containing 1.95 FALGPA (furanacryloyl-LeuGly-Pro-Ala) units/ml collagenase (Sigma), 75 units/ml elastase (Calbiochem, La Jolla, CA), and 1 mg/ml soybean trypsin inhibitor (Sigma) for 15 min at 37°C. The remaining fragments were rinsed two times with low Ca 2ϩ saline solution and gently triturated with a fire-polished Pasteur pipette to release single cells.
Cells were plated into a recording chamber on the stage of an inverted microscope and superfused with physiological saline solution (composed of (in mM): 136 NaCl, 5.9 KCl, 10 HEPES, 1.16 NaH 2 PO 4, 1.2 Cl 2 , 1.8 CaCl 2 , 18 D-glucose, 0.02 EGTA, and 2 pyruvate (pH adjusted to 7.4 with NaOH)) until recordings began. Current recordings were made between 30 min and 3 h after plating. Cells were refractile under interference contrast optics and contractile in solutions containing 140 mM K ϩ or 20 mM Ba 2ϩ . Patch Clamp Techniques-Whole-cell currents were recorded using an EPC-7 amplifier (HEKA, Darmstadt-Eberstadt, Germany) under the control of pClamp software (Axon Instruments, Foster City, CA) Analog to digital conversions were made using a TL-1 DMA interface (Axon) and stored on a Pentium computer for subsequent analysis. Data were sampled at 5-10 kHz and filtered at 1-2 kHz using an eight-pole Bessel filter. Hydraulic manipulators (MO-102, Narishige, Tokyo, Japan) were used for fine control of the micropipettes. All experiments were performed at 22°C.
Currents were recorded either in perforated patch (16) or conventional whole-cell mode (17) . The former mode was used whenever possible because the currents were more robust and stable with less potential for disruption of the normal intracellular environment. Pipettes had resistances ranging from 1 to 5 megaohms. Perforated patch pipettes were dipped for 2-3 s in a Cs ϩ pipette solution (high Cs ϩ ) containing, in mM, 110 CsCl and 20 tetraethylammonium-Cl to block endogenous K ϩ currents, 10 EGTA, 2 MgCl 2 , 10 HEPES, and 1 CaCl 2 (pH adjusted to 7.2 with CsOH). Pipettes were back-filled with the same solution containing 240 g/ml amphotericin B. For conventional wholecell recordings, a pipette solution (high Cs ϩ -CsF) containing, in mM, 100 CsCl, 25 CsF, 10 EGTA, 2 MgCl 2 , 10 HEPES, 5 BAPTA (1,2-bis(2-aminophenoxy)ethane-N,N,NЈ,NЈ-tetraacetic acid), and 5 MgATP (pH adjusted to 7.3 with CsOH) was used to block K ϩ currents and counteract the effects of run-down. For all recordings, Ba 2ϩ (20 mM) was used as the charge carrier, and the extracellular solution contained, in mM, 20 BaCl 2 , 124 choline chloride, 10 HEPES, and 15 D-glucose (pH adjusted to 7.4 with tetraethylammonium-OH). In most analyses, raw current values were normalized to cell capacitance (an index of cell size) and expressed as current density (pA/pF) for normalizing to control. Cell capacitance ranged from 4 to 16 pF.
Application of Reagents-Soluble antagonists (e.g. genistein, piceatannol, PP2) were applied locally to cells using Picospritzer pipettes (General Valve Corp., Fairfield, NJ). Insoluble ligands, FN (120 kDa, Life Technologies, Inc.), and anti-␣ 5 integrin antibody (HM␣5-1, CD49e; PharMingen, San Diego, CA), were coated onto 3.2-m diameter streptavidin-coated microspheres (Bangs Laboratories, Fishers, IN) using a biotinylation procedure and applied to individual cells using gentle aspiration from a second micropipette (10) . Peptides and antibodies were applied intracellularly by dialysis from the recording pipette using the conventional whole-cell recording mode. Under the conditions of these experiments, dialysis was 90% complete within 2 min after patch rupture, based on the time course of the change in the fluorescence signal when fluorescein isothiocyanate-dextran (30 -300 kDa) was added to the pipette solution.
Monoclonal Western Blotting-Freshly isolated cremaster smooth muscle cells were maintained in culture using 5% fetal bovine serum-supplemented Dulbecco's modified Eagle's medium for two to three passages to obtain sufficient numbers of cells for protein analysis. Cells were lysed in ice-cold buffer with the following composition: 1% sodium deoxycholate, 1% Nonidet P-40, 0.1% SDS, 10 mM Tris buffer (pH 8), 140 mM NaCl, 0.5 mg/ml Pefabloc, 1 g/ml leupeptin, 1 g/ml aprotinin, 1 g/ml pepstatin. Cell lysates containing equal amounts of protein were electrophoresed onto double cross-linked 7.5-and 9.5-16% gradient SDS-polyacrylamide gels under reducing conditions. After electrophoretic transfer to nitrocellulose, proteins were detected with the appropriate monoclonal antibodies. Peroxidase-conjugated donkey anti-mouse IgG (HϩL; Jackson Immunoresearch Labs, Inc., West Grove, PA) was used as the secondary antibody (dilution 1:50,000). Blots were developed using enhanced chemiluminescence (SuperSignal West Dura extended duration substrate, Pierce).
Expression and Purification of FRNK-Escherichia coli transformed with pET-His-tagged FRNK were obtained from J. T. Parsons (University of Virginia) and Joan Taylor (University of North Carolina). Bacterial cultures (500 ml) were induced with 0.3 mM isopropyl-1-thio-␤-Dgalactopyranoside for 3 h, pelleted by centrifugation, and frozen overnight at Ϫ80 degrees C. Bacteria were lysed by resuspension in B-PER (Pierce) with 300 mM NaCl and 1 l/ml protease inhibitor mixture (Calbiochem), and the lysate was cleared by centrifugation at 27,000 ϫ g. His-FRNK was purified using a Ni-NTA Spin Kit (Qiagen, Valencia, CA). Protein was eluted from each column using 50 mM NaH 2 PO 4 , 300 mM NaCl, and 300 mM imidazole at pH 8. SDS-polyacrylamide gel analysis of the effluent revealed two prominent bands. Proteins were transferred to a polyvinylidene difluoride membrane, and the N-terminal protein sequence was utilized to verify the presence of FRNK (Protein Sequencing Facility, Texas A&M University).
Immunofluorescence-Freshly isolated rat cremaster arteriolar myocytes were plated onto FN-coated glass coverslips and maintained in culture overnight. The cells were then fixed with phosphate-buffered saline containing, in mM, 2.7 KCl, 1.5 KH 2 PO 4 , 157 NaCl, and 8 NaH 2 PO 4 with 4% paraformaldehyde. Fixation was followed by two washes in phosphate-buffered saline containing 0.1 mM glycine. The cells were permeabilized in phosphate-buffered saline with 0.1% Triton X-100, rinsed three times, and incubated with an appropriate primary rat monoclonal antibody (dilution 1:100 -200) in phosphate-buffered saline containing 0.1% Triton X-100, 0.9% sodium citrate, and 0.025% NaN 3 for 60 min followed by three rinses. Cells were then incubated in Alexa-conjugated, secondary IgG (goat) in the same solution for 60 min, washed extensively, and treated with ProLong AntiFade (Molecular Probes). Fluorescence images were captured with an Orca-cooled charge-coupled device camera (CCD, Hamamatsu Inc., Bridgewater, NJ) using Metamorph hardware and software (Universal Imaging Corp., West Chester, PA). Background fluorescence in each preparation was determined by excluding the primary antibody step from the staining procedure.
Statistical Analysis-Statistical comparisons were performed with repeated-measures analysis of variance followed by post-hoc tests or with an independent two-tailed t test, as appropriate. Averaged values are expressed as mean Ϯ S.E., and p values Ͻ 0.05 were considered significant.
RESULTS

Enhancement of L-type Calcium Current by Insoluble
Ligands-Current through the L-type calcium channel was elicited using voltage ramps (Ϫ100 to ϩ80 mV, duration ϭ 200 ms) or steps (Ϫ80 to ϩ80 mV in 10-mV increments, duration ϭ 100 ms). Both protocols elicited inward, whole-cell Ba 2ϩ currents that peaked at ϩ30 mV (range ϭ Ϫ3.0 to Ϫ10.4 pA/pF) and were blocked by nifedipine. In the perforated patch recording mode, currents were stable for more than 30 min, but application of insoluble ␣ 5 ␤ 1 integrin ligands coated onto beads resulted in enhancement of L-type current within 1 min after the beads had contacted the cell (Fig. 1A) . The degree to which this current was enhanced depended on the integrin ligand; FN-coated beads produced a 35% increase in current, whereas beads coated with ␣ 5 antibody enhanced current by 70% above basal levels. Both effects were larger than those produced by PKC agonists in this preparation (18) . We have previously shown that the ␣ 5 antibody effect is greater than that of FN because FN also interacts with ␣ v ␤ 3 integrin in this cell type to negatively modulate L-type current (10) . The enhancement in current shown in Fig. 1 was specific to integrins because no significant change was observed when cells were presented with uncoated beads (10), albumin-coated beads (10), or beads coated with a non-integrin antibody (MHC, Fig. 1B , open circles). The current enhanced by insoluble ␣ 5 ␤ 1 ligands was not sustained indefinitely but reached a peak 2-4 min after bead attachment followed by a gradual return to base line at 12-16 min, even though the beads remained attached throughout. This spontaneous recovery could be due to a number of mechanisms, such as a change in ␣ 5 ␤ 1 affinity or an intracellular feedback loop, but investigation of these mechanisms was beyond the scope of this study.
In the conventional whole-cell recording mode, a response similar to that induced by insoluble ␣ 5 ␤ 1 ligands was observed, but the time course and magnitude were slightly different. This mode was required in subsequent protocols to allow dialysis of cells with antibodies to specific intracellular proteins (Fig. 1C) . L-type currents in this recording mode were not as stable over time, as shown in Fig. 1D . Ligand-coated beads were added to cells 4 min after patch rupture when L-type current had typically "run up" to its maximal value. Cells presented with anti-␣ 5 beads showed an additional increase in L-type current (68% on average) between 4 and 14 min, whereas cells presented with albumin-or IgG-coated beads showed only the gradual decline in current characteristic of run-down (Fig. 1D) . The difference between these two curves was very similar to the time course of the enhanced current recorded in perforated patch mode (Fig. 1B) . A similar pattern was observed when cells were presented with FN-coated beads, although the magnitude of the enhancement was smaller than for ␣ 5 -coated beads (data not shown).
Effect of Tyrosine Kinase Inhibition on ␣ 5 ␤ 1 -enhanced Current-Integrin ligation by insoluble, multivalent ligands is known to be associated with clustering of receptors and subsequent accumulation of cytoskeletal proteins and integrin-associated kinases in the focal adhesion complex (6, 7). Furthermore, several signaling pathways downstream from integrin ligation involve tyrosine phosphorylation of focal adhesion proteins. Therefore, we tested the hypothesis that a tyrosine phosphorylation step was required for modulation of L-type current.
Soluble tyrosine kinase inhibitors prevented the enhancement of L-type current by insoluble ␣ 5 ␤ 1 ligands, as shown in Fig. 2 . Piceatannol (10 M) is known to block several Src family tyrosine kinases (19) . In the perforated patch recording mode, bath application of piceatannol caused a 26% reduction in basal current, consistent with previous conclusions that the L-type calcium channel may be constitutively phosphorylated by a tyrosine kinase (20) . The attachment of FN-coated beads in the absence of piceatannol was associated with a 35-40% increase in current that peaked 2 min after bead attachment; a similar effect was noted on current enhanced by ␣ 5 -coated beads (not shown). Application of piceatannol at this point in time caused a reduction in current to 70% of control (whereas beads remained attached). Thus, piceatannol not only inhibited basal current but also inhibited the ␣ 5 ␤ 1 -induced enhancement in current.
This protocol was repeated using another tyrosine kinase inhibitor, genistein (100 M), with qualitatively the same result; genistein both inhibited the basal current (to 22 Ϯ 2% of control 2 min after genistein application; n ϭ 5), and completely blocked the response to FN-coated beads. The larger effect of genistein on basal current is consistent with this dosage also inhibiting serine-threonine kinases (21) . The data for piceatannol and genistein are summarized in Fig. 3 . The inactive genistein analog, daidzein (100 M) had no significant effect on either component of current (n ϭ 4). In contrast, the phosphatase inhibitor phenylarsine oxide (100 M), increased basal current (to 38% of control) and increased the magnitude of the ␣ 5 antibody-enhanced current (to 22% of control). Both effects were statistically significant, and it is likely that the magnitude of the latter effect might have been underestimated because of the large shift in base-line current.
These results point to a possible role for a tyrosine phosphorylated protein or proteins in this response, but soluble tyrosine kinase inhibitors are also reported to inhibit serine-threonine kinases (22) and have direct interactions with channels (23) (24) (25) . To address this possibility, we tested the effect of PKC inhibition on current (Fig. 3) . Protein kinase C is known to enhance calcium entry and the contraction of smooth muscle in part by altering the voltage sensitivity of the L-type channel at a PKC-specific phosphorylation site (26) . We have previously shown that PKC activators enhance L-type current by as much as 30% under conditions similar to these in VSM (18) . Using the conventional whole-cell recording mode, the PKC-specific inhibitory peptide, PKC-(19 -36), was dialyzed into cells from the patch pipette. As shown in Fig. 3 , basal current was decreased by 24% in PKC-(19 -36)-treated cells (50 M, n ϭ 7) but not in cells dialyzed with a control peptide, [Glu 27 ]PKC-(19 -36) (50 M, n ϭ 8). However, the increase in current produced by anti-␣ 5 -coated beads was not significantly affected by either PKC peptide.
Effect of Intracellular Dialysis with Anti-pp125 FAK -To elucidate the specific kinases and other proteins required for ␣ 5 ␤ 1 regulation of L-type current, the conventional whole-cell recording mode was used so that cells could be dialyzed with pipette solutions containing monoclonal antibodies directed to specific proteins. FAK is a prominent, non-receptor tyrosine kinase in focal adhesions and is known to undergo rapid tyrosine phosphorylation following integrin ligation and clustering (9) . Integrin-dependent autophosphorylation of FAK allows it to interact with other focal adhesion proteins, including paxillin and tensin, which in turn are able to activate downstream signaling molecules such as Src and Ras (8) . Dialysis of cells with a monoclonal antibody to pp125 FAK (7.5 g/ml) resulted in a 24% reduction of basal L-type current (Fig. 4A, open bars) . In the presence of the anti-FAK antibody, the magnitude of the current enhanced by anti-␣ 5 beads was inhibited by 63% (filled bars). This effect was measured 2-4 min after application of beads, when the current enhanced by ␣ 5 antibody was maximal. As shown in Fig. 4B , neither the threshold nor the reversal potential of the current was altered by anti-FAK. As a partial control for the specificity of anti-FAK on current, an anti-mouse IgG antibody (10 g/ml) did not significantly alter either component of current (Fig. 4A ). Fig. 4B shows the normalized current-voltage relationship for the L-type channel measured under control conditions, after anti-␣ 5 beads, and after anti-␣ 5 bead application with simultaneous intracellular dialysis with anti-FAK. Because the current was modulated over the entire range of activation voltages, neither the integrin ligands nor the FAK antibody appeared to act by shifting the voltage sensitivity of the channel.
Immunofluorescence and immunoblotting experiments with this antibody revealed focal adhesion staining and a 120-kDa protein on Western blots in arteriolar smooth muscle cells, consistent with known FAK distribution (Fig. 5) .
As an alternative to the use of an antibody for which intracellular distribution and mechanism of action were uncertain, we dialyzed another group of cells with FRNK, a C-terminal, noncatalytic domain of FAK lacking tyrosine kinase activity (27) . FRNK has been shown localize to focal adhesions and inhibit endogenous FAK function (28) . Dialysis of VSM cells with FRNK produced an 18% inhibition of basal Ca 2ϩ current and 68% inhibition of integrin-enhanced Ca 2ϩ current (Fig. 4) . In contrast, dialysis of VSM cells with lysate from control bacteria (without FRNK cDNA) that were induced by isopropyl-1-thio-␤-D-galactopyranoside did not produce a significant effect on current.
Effects of Src Inhibition and Activation-Autophosphorylation of FAK at Tyr
397 is known to create a high affinity binding site for the SH2 domains of Src family kinases, releasing autoinhibition of Src. The FAK-Src interaction results in further phosphorylation of FAK allowing interaction with other focal adhesion proteins such as paxillin and PI3-kinase (8) . Recent evidence suggests that in smooth muscle Src may be associated with ␣1c, the pore-forming subunit of the L-type channel (14) , and inhibition of Src is known to attenuate basal L-type current in smooth muscle (29, 30) . For these reasons, we tested the involvement of Src in the component of current regulated by
Using the conventional whole-cell recording mode, a monoclonal antibody to pp60 c-Src was dialyzed into the cells, while recording basal L-type current or the current enhanced follow- ing application of anti-␣ 5 beads (Fig. 6) . In cells dialyzed with the antibody, there was a 73% reduction in basal current (open bars) and 79% reduction in ␣ 5 -enhanced current (filled bars). Dialysis with anti-Src and anti-FAK together resulted in nearly complete inhibition of ␣ 5 -enhanced current.
As an additional test for the efficacy and specificity of Src inhibition, we applied the soluble Src inhibitor, PP2 (100 nM), while recording L-type current in perforated patch mode. PP2 inhibits Src by interacting specifically with a pocket in the Src SH2 domain (31) . PP2 produced a similar pattern of inhibition as the FAK antibody with a moderate effect on basal current (20% inhibition) but a rather substantial effect on ␣ 5 -enhanced current (77% inhibition; Fig. 6 ). The related but inactive compound, PP3, at the same concentration was without significant effect on either basal or ␣ 5 -enhanced current. Next, we tested the effects of an inhibitory peptide specific to the Src SH2 domain (32) using the conventional whole-cell recording mode to permit dialysis of the cells with the peptide. A similar pattern of inhibition was observed as for PP2; the peptide inhibited basal current by 18% and had an even greater effect (82% inhibition) on the component of current enhanced by anti-␣ 5 beads. In contrast, dialysis of cells with a constitutively active form of Src (33) increased basal current by 34% and had no significant effect on the current enhanced by anti-␣ 5 beads.
Immunofluorescence and immunoblotting experiments with the anti-Src monoclonal antibody were consistent with localization of Src to focal adhesions in this cell type (not shown). (8), with FAK recruiting Src family kinases to the focal adhesion and Src catalyzing the tyrosine phosphorylation of other focal adhesion proteins (34) . FAK has binding domains for the CSK proteins paxillin and talin and for docking and adaptor proteins such as Cas and Grb2. Interactions with these proteins may initiate recruitment of other Src domain kinases to the focal adhesion or may be required for proper FAK-Src interactions. Therefore, we tested the effects of antibodies to several CSK proteins known to be recruited to focal adhesions following integrin activation. These results are summarized in Fig. 7 .
Effects of Dialysis with Antibodies to Other Focal Adhesion Proteins-It has been suggested that FAK and Src coordinately regulate tyrosine phosphorylation events in focal adhesions
Dialysis with antibodies to paxillin or vinculin significantly affected both basal L-type current and ␣ 5 -enhanced current. The relative inhibition of the two components of current was very similar to the pattern produced by the FAK antibody and Src inhibitors. Basal current was inhibited by 24% after dialysis with the paxillin antibody and by 19% with the vinculin FIG. 3 . Summary of the effects of general tyrosine kinase inhibition and PKC inhibition. All currents were normalized to their respective control values. Open bars (Ⅺ) are normalized current in the absence of coated beads (i.e. basal current), and filled bars (f) are current in the presence of beads coated with ␣ 5 antibody (i.e. current enhanced by ␣ 5 ␤ 1 ligation and clustering). For PKC inhibitory peptide (Ⅺ: n ϭ 7; f: n ϭ 10) or PKC control peptide (Ⅺ: n ϭ 8; f: n ϭ 10) protocols, test measurements were made 6 min after breakthrough to the conventional whole-cell recording mode. For piceatannol (Ⅺ: n ϭ 7; f: n ϭ 7), genistein (Ⅺ: n ϭ 5; f: n ϭ 5), phenylarsine oxide (Ⅺ: n ϭ 7; f: n ϭ 6) or daidzein (Ⅺ: n ϭ 4; f: n ϭ 4) protocols, the test measurements were made 2-4 min after application of ␣ 5 antibody-coated beads in perforated whole-cell recording mode. *, p Ͻ 0.05 compared with absence of beads (Ⅺ) or ␣ 5 antibody-coated beads alone (f).
FIG. 4. Effect of intracellular dialysis with FAK antibody and FRNK.
Open bars (Ⅺ) are normalized current in the absence of coated beads (i.e. basal current), and filled bars (f) are current in the presence of beads coated with ␣ 5 antibody. A, summary of normalized currents when cells were dialyzed with monoclonal anti-pp125 FAK (Ⅺ: n ϭ 10; f: n ϭ 10), FRNK (Ⅺ: n ϭ 10; f: n ϭ 8), lysate from bacteria induced without FRNK cDNA (Ⅺ: n ϭ 7; f: n ϭ 7) or anti-mouse-IgG (Ⅺ: n ϭ 8; f: n ϭ 8). Measurements were made 6 min after breakthrough to the conventional whole-cell recording mode. *, p Ͻ 0.05 compared with absence of beads (Ⅺ) or ␣ 5 antibody-coated beads alone (f). B, traces showing current-voltage relationship during control conditions (n ϭ 9), after dialysis with anti-FAK antibody (n ϭ 10), and after attachment to beads coated with ␣ 5 antibody with (n ϭ 10) or without (n ϭ 9) dialysis with anti-FAK antibody.
antibody, whereas integrin-enhanced current was inhibited by 83% by the paxillin antibody and 65% by the vinculin antibody (Fig. 7) . In contrast, dialysis with an ␣-actinin antibody was without significant effect on either component of current.
Immunofluorescence and immunoblotting experiments with the monoclonal antibodies to paxillin (Fig. 5 ) and vinculin were consistent with localization of these proteins to focal adhesions in this cell type. This was also the case for ␣-actinin, even though it did not have a significant effect on L-type current.
Recent studies using the neuronal isoform of ␣1c have revealed that the intracellular C terminus of that protein can be tyrosine phosphorylated by Src in response to the growth factor IGF-1 (15) . IGF-1 application resulted in enhancement of Ca 2ϩ current, an effect similar in time course and magnitude to that of clustered ␣ 5 integrin antibody in our experiments (Fig. 1) . The C terminus of the neuronal isoform contains two putative tyrosine phosphorylation sites at Tyr 2134 and Tyr 2122 , and sitedirected mutagenesis of Y2122F in exogenously expressed channels produces Ca 2ϩ currents that are resistant to modulation by IGF-1 (15) . Because VSM (Cav1.2b) and neuronal (Cav1.2c) isoforms show exact sequence identity over these regions (35) , we hypothesized that phosphorylation of Tyr 2122 might also be involved in the modulation of VSM Ca 2ϩ current in response to ␣ 5 ␤ 1 ligands. To test this idea in our native cell system where channel expression levels are low and sufficient quantities of protein for immunoblotting protocols are impractical to obtain, we manufactured peptides that would compete with the binding of tyrosine kinases, presumably c-Src, to this region. Fig. 8 summarizes the results of the experiments. Dialysis of VSM cells with an 11-amino acid peptide sequence identical to the ␣1c C terminus from Glu 2116 to Arg 2126 inhibited basal Ca 2ϩ current by 21 Ϯ 3% and inhibited the component of current enhanced by anti-␣ 5 -coated beads by 73 Ϯ 3%. In contrast, neither of two control peptides, an identical peptide except for Phe at position 2122 or a second peptide with Tyr at position 2122 but with the other 10 amino acids scrambled, produced a significant effect on calcium current (Fig. 8) . These findings suggest that tyrosine phosphorylation at this site on the VSM calcium channel is responsible for the enhancement in current observed after application of ␣ 5 ␤ 1 integrin ligands.
DISCUSSION
Our results support the conclusion that regulation of the L-type calcium channel by the ␣ 5 ␤ 1 integrin involves tyrosine phosphorylation and complex formation of multiple focal adhesion proteins. In vascular smooth muscle, engagement of this integrin by insoluble ␣ 5 integrin antibody or FN led to enhancement of L-type calcium current under conditions where the ligand was clustered. Regulation of calcium current by ␣ 5 ␤ 1 integrin was blocked by broad spectrum inhibitors of tyrosine kinases or by targeting FAK or Src tyrosine kinases with specific antibodies. Tyrosine kinase inhibition had significant but less profound effects on basal L-type calcium current, whereas PKC inhibition produced selective inhibition of basal calcium current. Monoclonal antibodies to two integrin-associated cytoskeletal protein targets, paxillin and vinculin, also blocked regulation of current by ␣ 5 ␤ 1 ligands. All of these proteins were localized to VSM focal adhesions. Finally, a peptide directed at a putative tyrosine phosphorylation site on the C-terminal loop of the ␣1c channel protein blocked regulation of current by ␣ 5 ␤ 1 ligands. Our data support a role for direct regulation of calcium entry by ␣ 5 ␤ 1 integrin, with the potential for this effect to be greater than that described for serine-threonine kinases. It is likely that Src tyrosine kinase directly or indirectly mediates this effect. We propose that extracellular matrix exerts constitutive control over the major calcium-permeable ion channel in VSM and that acute regulation of calcium signaling by integrins may occur under physiological and pathological conditions in blood vessels.
This conclusion is consistent with recent evidence that integrin ligands and ECM proteins can acutely regulate vascular tone. For example, RGD peptides cause a transient constriction and then dilation of isolated, pressurized skeletal muscle arterioles when applied extraluminally (36) . The dilatory phase is associated with a fall in VSM intracellular calcium (37) and is blocked by a ␤ 3 integrin antibody (36) . In contrast, ␣ 5 ␤ 1 integrin ligands produce sustained constrictions of the same arterioles that are mediated by endothelin-1 release from the endothelium (38) ; however, the initial, transient constriction is endothelium-independent. The responses of arterioles to ␣ v ␤ 3 and ␣ 5 ␤ 1 integrin ligands (inhibition and enhancement, respectively) are consistent with the effects produced by these ligands on L-type calcium current in single arteriolar smooth muscle cells (10) . This evidence indicates that extracellular matrix proteins have the potential to influence vascular tone through an interaction with integrins, pointing to a possible role for these mechanisms in tissue injury responses (39) .
A growing body of evidence now suggests that phosphorylation of voltage-gated ion channels by protein tyrosine kinases is a general mechanism of acute channel regulation (40) . However, the majority of those studies have focused on K ϩ channels. For example, deficiency in p56 lck tyrosine kinase abolishes Fas-mediated inhibition of Kv1.3 current, whereas reconstitution of p56 lck restores the effect (41) . Epidermal growth factor inhibits Kv1.5 (42) , probably through Src kinase, because co-expression of Src and hKv1.5 in HEK cells results in tyrosine phosphorylation of the channel and suppression of current (43) . Studies of cloned K v , K ir , and K Ca channels have revealed specific tyrosine residues on the N-and C-terminal loops of the ␣ subunits that are involved in channel regulation (42, 44, 45) . Phosphorylation leads, in almost all cases, to inhibition of current. However, the functional effects of K ϩ channel tyrosine phosphorylation in native cells are not very well known.
In excitable cells, the voltage-gated L-type Ca 2ϩ channel constitutes the primary calcium influx pathway used by depolarizing stimuli and many G-protein-coupled agonists (20) . Regulation of this channel by serine-threonine kinases is well established (46) , but regulation by tyrosine kinases has only recently been described (15, 47) . Tyrosine kinases have also been implicated in the regulation of the pore-forming subunits of voltage-gated calcium channels, including ␣1e (48), ␣1d (49), and ␣1c (50, 51) . In visceral smooth muscle, the ␣1c channel subunit (Cav1.2b) co-immunoprecipitates with both c-Src and anti-phosphotyrosine antibodies (14) . In cerebellar neurons, the neuronal isoform of ␣1c (Cav1.2c) is tyrosine-phosphorylated in response to IGF-1, resulting in potentiation of L-type current (47, 52) . This effect can be duplicated in recombinant Cav1.2c channels expressed in SH-SY5Y cells. Potentiation requires c-Src because expression of kinase-dead Src blocks potentiation of current (15) . Kinase assays using lysates from neuroblastoma cells expressing Cav1.2c show that purified Src kinase phosphorylates Tyr 2122 of the C terminus. Furthermore, point mutation of Y2122F (but not of a nearby tyrosine residue) prevents tyrosine phosphorylation and prevents IGF-1 potentiation of current (15) . Because Cav1.2b and Cav1.2c share identical sequences in this region, it is likely that Tyr 2122 (rather than other postulated sites (14, 53) ) also mediates the platelet-derived growth factor potentiation of current in smooth muscle. Our results with a peptide inhibitor directed against this region (Fig. 8) indicate that integrin-mediated enhancement of Cav1.2b current requires phosphorylation of this tyrosine residue. Although direct phosphorylation of VSM ␣1c (Cav1.2b) by Src or another Src family kinase has not yet been demonstrated, this site may be a common regulatory site for integrin and growth factor signaling pathways (14, 30, 54) . It is interesting to note that the cardiac isoform of ␣1c (Cav1.2a) does not contain this tyrosine and that cardiac L-type channels are resistant to potentiation by IGF-1 (15) .
Regulation of the L-type calcium channel by a tyrosine kinase in the focal adhesion complex is consistent with an emerg- FIG. 6 . Effect of Src inhibitors and activated Src. All currents were normalized to their respective control values. Open bars (Ⅺ) are normalized currents in the absence of coated beads (i.e. basal current), and filled bars (f) are current in the presence of beads coated with ␣ 5 antibody. For the monoclonal Src antibody (Ⅺ: n ϭ 9; f: n ϭ 8), Src SH2 domain inhibitor peptide (Ⅺ: n ϭ 7; f: n ϭ 8), anti-FAK ϩ anti-Src (Ⅺ: n ϭ 6; f: n ϭ 9), or activated Src kinase (Ⅺ: n ϭ 9; f: n ϭ 9) protocols, the test measurements were made 6 min after breakthrough to the conventional whole-cell recording mode. For Src kinase inhibitor PP2 (Ⅺ: n ϭ 7; f: n ϭ 7) or negative control for Src kinase inhibitor PP3 (Ⅺ: n ϭ 8; f: n ϭ 6) protocols, the test measurements were made 2-4 min after application of ␣ 5 antibody-coated beads in perforated patch recording mode. *, p Ͻ 0.05 compared with absence of beads (Ⅺ) or ␣ 5 antibody-coated beads alone (f).
FIG. 7. Effect of intracellular application of CSK antibodies.
Open bars (Ⅺ) are normalized currents in the absence of coated beads (i.e. basal current), and filled bars (f) are current in the presence of beads coated with ␣ 5 antibody. Summary of normalized currents when cells were dialyzed with monoclonal anti-paxillin (Ⅺ: n ϭ 9; f: n ϭ 9), anti-vinculin (Ⅺ: n ϭ 9; f: n ϭ 9) or anti-␣-actinin (Ⅺ: n ϭ 10; f: n ϭ 8). Measurements were made 6 min after breakthrough to the conventional whole-cell recording mode. *, p Ͻ 0.05 compared with absence of beads (Ⅺ) or ␣ 5 antibody-coated beads alone (f).
FIG. 8.
Effect of intracellular application of peptides to compete with a putative Src phosphorylation site on the channel. Open bars (Ⅺ) are normalized currents in the absence of coated beads (i.e. basal current), and filled bars (f) are current in the presence of beads coated with ␣ 5 antibody. This is a summary of normalized currents when cells were dialyzed with peptide A (Ⅺ: n ϭ 9; f: n ϭ 10), peptide B (Ⅺ: n ϭ 10; f: n ϭ 10), or peptide C (Ⅺ: n ϭ 9; f: n ϭ 8). Peptide A contained the same 11-amino acid sequence as the Ca 2ϩ channel C terminus from 2116 to 2126. Peptide B was the same as peptide A except that Phe was substituted for Tyr at position 2122. Peptide C contained the same 11 amino acids as peptide A, with a Tyr at position 2122 but with the other positions scrambled. Measurements were made 6 min after breakthrough to the conventional whole-cell recording mode. *, p Ͻ 0.05 compared with the absence of beads (Ⅺ) or ␣ 5 antibody-coated beads alone (f).
ing view that CSK proteins are key components for ion channel regulation. Evidence from a number of studies suggests that various structural proteins, including actin (55), synaptin (56) , tenascin (57) , and ankyrin (58) , are required for normal regulation of voltage-gated ion channels. Their role may be analogous to that of protein kinase A (PKA)-anchoring proteins in the regulation of Ca 2ϩ and K ϩ channels by PKA, where PKAanchoring proteins 15/18 and 79 are needed for PKA targeting to Ca 2ϩ and K ϩ channels, respectively (59) . For example, Ltype calcium channels associate with at least three different synaptic vesicle proteins in secretory cells, and grouping of the channel in this multi-protein complex is required for normal function (56) . In our experiments, the ability of vinculin and paxillin antibodies to inhibit the enhancement of L-type current by ␣ 5 ␤ 1 ligands is probably because of interference by the antibodies with the assembly of Src or another tyrosine kinase on an intracellular scaffolding of focal adhesion proteins rather than a direct interaction with the channel. These CSK proteins have no intrinsic kinase activity, but some, like paxillin, can be phosphorylated to alter their ability to associate with other proteins (8) . Although there are at least 15 other known proteins in the focal adhesion complex (7) that we have not tested, it is interesting that the only antibodies effective in blocking ␣ 5 ␤ 1 enhancement of L-type current were those directed against focal adhesion proteins containing SH2 or SH3 domains. These are regions that would potentially enable these proteins to associate with tyrosine kinases, and ␣-actinin contains neither of them (8) . Importantly, the ␣1c channel subunit contains an SH3 region in its C-terminal, intracellular loop (60) that may allow it to interact with Src or other focal adhesion proteins, as is the case for an SH3 domain in the hKv1.5 channel (43) . The exact sequence of events from integrin ligation to calcium channel regulation will be difficult to unravel, but elucidation of this pathway may produce a new view of how voltage-gated calcium channels are regulated by ECM.
